Stocks in play: Nextleaf Solutions Ltd
Provides an update on its Specialty Molecules division, specifically the Company's patented novel route of manufacturing D9-tetrahydrocannabinol acetate colloquially referred to as THC-O. Nextleaf has recently produced THC-O under the Company's Health Canada Research Licence in anticipation of commercialization. Nextleaf has validated its manufacturing process of THC-O through third-party analytical testing. Nextleaf Solutions Ltd shares C.OILS are trading up 7.7% at $0.07.
Read:
Innovative Food Stocks Responding to Conflict-, and Drought-Driven Food Supply Shocks
Crypto Miners Finding Success While Shifting Towards Environmentally Sustainable Operations
New Approaches Towards Immunotherapy Give Hope in Fight Against Solid Tumors
As a Major Social Media Shuffle Looms, Uptake and Value of Dogecoin (DOGE) Surges
New Regions Being Developed to Produce More Oil Amid Government’s Calls for More Output